English   español  

Browsing by Author Chioua, Mourad

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 36 of 36 < previous 
RightsPreviewIssue DateTitleAuthor(s)Type
openAccessWO2013017715A2.pdf.jpg7-Feb-2013Quinolyl nitronesChioua, Mourad ; Samadi, Abdelouahid ; Soriano, Elena ; Marco-Contelles, José ; Oset Gasque, María Jesús; Alcázar González, Albertopatente
openAccessmolecules-24-01503.pdf.jpg17-Apr-2019QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease TherapyRamos, Eva; Palomino-Antolín, Alejandra; Bartolini, Manuela; Iriepa, Isabel; Moraleda, Ignacio; Diez-Iriepa, Daniel; Samadi, Abdelouahid ; Cortina, Carol V.; Chioua, Mourad ; Egea, Javier; Romero, Alejandro ; Marco-Contelles, José artículo
closedAccessaccesoRestringido.pdf.jpg2014Silver triflate-catalyzed cyclization of 2-amino-6-propargyl- amineazines leading to iminoimidazoazinesChioua, Mourad ; Samadi, Abdelouahid ; Soriano, Elena ; Infantes, L. ; Marco-Contelles, José artículo
closedAccessaccesoRestringido.pdf.jpg2013Silver-catalyzed cyclization of N-(prop-2-yn-1-yl)pyridin-2-aminesChioua, Mourad ; Soriano, Elena ; Infantes, L. ; Jimeno, M. Luisa; Marco-Contelles, José ; Samadi, Abdelouahid artículo
openAccessES2379919A1.pdf.jpg7-May-2012Síntesis de piridonas bicíclicas que contienen el sistema heterocíclico de imidazo[1,2-a]piridina, a partir de 2-amino-6-(prop-2-in-1-ilamino)piridinasSamadi, Abdelouahid ; Marco-Contelles, José ; Sucunza Sáez, David; Chioua, Mourad solicitud de patente
closedAccessaccesoRestringido.pdf.jpg2017Synthesis and biological assessment of racemic benzochromenopyrimidinetriones as promising agents for Alzheimer's disease therapyDgachi, Youssef; Martin, Hélène; Bonet, Alexandre; Chioua, Mourad ; Iriepa, Isabel; Moraleda, Ignacio; Chabchoub, Fakher; Marco-Contelles, José ; Ismaili, Lhassaneartículo
openAccessmolecules-21-00634.pdf.jpg14-May-2016Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s DiseaseDgachi, Youssef; Bautista-Aguilera, Óscar M.; Benchekroun, M.; Martin, Hélène; Bonet, Alexandre; Knez, Damijan; Godyń, Justyna; Malawska, Bárbara; Gobec, Stanislav; Chioua, Mourad ; Janockova, Jana; Soukup, O.; Chabchoub, Fakher; Marco-Contelles, José ; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2011Synthesis and pharmacological assessment of diversely substituted pyrazolo[3,4-b]quinoline, and benzo[b]pyrazolo[4,3-g][1,8]naphthyridine derivativesSilva, Daniel; Chioua, Mourad ; Samadi, Abdelouahid ; Carreiras, M. Carmo; Jimeno, M. Luisa ; Mendes, Eduarda; Ríos, Cristóbal de los; Romero, Alejandro ; Villarroya, Mercedes; Marco-Contelles, José artículo
closedAccessaccesoRestringido.pdf.jpg2015Synthesis of 5-amino-3,3-dimethyl-7-phenyl-3H-[1,2]oxathiolo[4,3-b]pyridine-6-carbonitrile 1,1-dioxidesChioua, Mourad ; Samadi, Abdelouahid ; Postel, D.; Balzarini, Jan; Marco-Contelles, José artículo
closedAccessaccesoRestringido.pdf.jpg2011Synthesis, analytical features, and biological relevance of 5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone, a microbial metabolite derived from the catabolism of dietary flavan-3-olsSánchez-Patán, Fernando ; Chioua, Mourad ; Garrido, Ignacio; Cueva, Carolina  ; Samadi, Abdelouahid ; Marco-Contelles, José ; Moreno-Arribas, M. Victoria  ; Bartolomé, Begoña  ; Monagas Juan, María Josefina artículo
closedAccessaccesoRestringido.pdf.jpg2018Synthesis, Biological Assessment and Molecular Modeling of Racemic QuinoPyranoTacrines for Alzheimer's Disease TherapyChioua, Mourad ; Serrano, Estefanía; Dgachi, Youssef; Martin, Helene; Jun. Daniel Jun; Janockova, Jana; Sepsova, Vendula; Soukup, Ondrej; Moraleda, Ignacio; Chabchoub,Fakher; Ismaili, Lhassan; Iriepae, Isabel; Marco-Contelles, José artículo
closedAccessaccesoRestringido.pdf.jpg2013Synthesis, pharmacological assessment, and molecular modeling of acetylcholinesterase/butyrylcholinesterase inhibitors: Effect against amyloid-β-induced neurotoxicitySilva, Daniel; Chioua, Mourad ; Samadi, Abdelouahid ; Agostinho, Paula; Garção, Pedro; Lajarín-Cuesta, Rocío.; Ríos, Cristobal de los; Iriepa, Isabel; Moraleda, Ignacio; Gonzalez-Lafuente, Laura; Mendes, Eduarda; Pérez, Concepción; Rodríguez-Franco, María Isabel ; Marco-Contelles, José ; Carreiras, M. Carmoartículo
openAccessBMC-D-10-01361 (2).pdf.jpg2011Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemiaSamadi, Abdelouahid ; Soriano, Elena ; Revuelta, Julia ; Valderas, Carolina; Chioua, Mourad ; Garrido, Ignacio; Bartolomé, Begoña  ; Villarroya Sánchez, Mercedes; Marco-Contelles, José artículo
closedAccessaccesoRestringido.pdf.jpg2018Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, asmulti-target-directed ligands for Alzheimer's diseaseChioua, Mourad ; Buzzi, Eleonora; Moraleda, Ignacio; Iriepa, Isabel; Maj, Maciej; Wnorowski, Artur; Giovannini, Catia; Tamarin, Anna; Portali, Federica; Ismaili, Lhassane; López-Alvarado, Pilar; Bolognesi, Maria Laura; Jozwiak, Krzysztof; Menéndez, J. Carlos; Marco-Contelles, José ; Bartolini, Manuelaartículo
closedAccessaccesoRestringido.pdf.jpg2014The reaction of 2-amino-4 H-pyrans with N-bromosuccinimideSamadi, Abdelouahid ; Silva, Daniel; Chioua, Mourad ; Infantes, L. ; Soriano, Elena ; Marco-Contelles, José artículo
closedAccessaccesoRestringido.pdf.jpg2014Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9, 10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's diseaseOset-Gasque, María Jesús; González, María Pilar; Pérez-Peña, Javier; García-Font, Nuria; Romero, Alejandro ; Pino, Javier del; Ramos, Eva; Hadjipavlou-Litina, Dimitra; Soriano, Elena ; Chioua, Mourad ; Samadi, Abdelouahid ; Raghuvanshi, Dushyant S.; Singh, Krishna N.; Marco-Contelles, José artículo